نتایج جستجو برای: medullary thyroid cancer

تعداد نتایج: 982512  

AFSAR ASADI, MANOOCHEHR NAKHJAVANI, MOHAMMAD HASAN BASTANHAGH, MOHAMMAD RAJAI, RADINA ESHTIAGHI, REZA KASSAYAN,

We studied the clinical, radioisotopic, and pathologic characteristics and the incidence of cancer in clinically solitary cold nodules of the thyroid in an iodinedeficient area. The study included retrospective analysis of 765 patients who underwent thyroidectomy for a clinically single cold nodule in a ten-year period. We compared the pathological findings with clinical data. In pathologic...

Journal: :Annals of nuclear medicine 2001
S Sato Y Okumura A Tamizu K Maki S Akaki Y Takeda S Kanazawa Y Hiraki

We report a case of Sipple's syndrome with a hepatic tumor. A 28-year-old male with medullary thyroid cancer and bilateral pheochromocytomas was diagnosed as having Sipple's syndrome. The hepatic tumor was found to be hypervascular by means of a dynamic abdominal CT scan. An I-131-MIBG scan showed no increased accumulation in the tumor. A whole body Tc-99m-MIBI scan had shown, however, increase...

Journal: :Endocrine-related cancer 2007
Paolo Miccoli Michele N Minuto Clara Ugolini Eleonora Molinaro Fulvio Basolo Piero Berti Aldo Pinchera Rossella Elisei

Total thyroidectomy and central neck dissection are the procedures of choice in patients affected with medullary thyroid cancer. It is known that a medullary thyroid cancer with node metastases can be rarely cured, and therefore the utility of a modified radical neck dissection in the absence of suspicious node metastases still needs further evidence. The study aims to verify whether other epid...

فرشته انسانی, , کامبیز مظفری, ,

Nodules in the thyroid have always commanded a great deal of attention because of the fear of their being cancerous. The estimated incidence of thyroid nodules in children and young adults is about 0.22 to 1.8 percent. According to different epidemiological data, about 10 to 35 percent of thyroid cancers occur in the first two decades. The present study based on microscopic review of tissue sli...

Journal: :Cleveland Clinic journal of medicine 2015
Subramanian Kannan Christian Nasr

The question is complicated, as there are different types of thyroid cancer, and a causal relationship is hard to prove. Glucagon-like peptide 1 (GLP-1) receptor agonists can be safely used in all patients with thyroid cancers that are derived from the thyroid follicular epithelium (papillary and follicular thyroid cancer). However, they are currently contraindicated in patients with medullary ...

Journal: :Archives of surgery 2004
Andreas Machens Hans-Jürgen Holzhausen Henning Dralle

HYPOTHESIS Discontinuous nodal metastasis, or skip metastasis, in thyroid cancer may display clinicopathologic features different from those seen in continuous nodal metastasis and thus may have a different prognosis. DESIGN Retrospective analysis. SETTING Tertiary referral center at a university hospital. PATIENTS Two hundred fifteen consecutive patients who underwent systematic central ...

Journal: :medical journal of islamic republic of iran 0
manoochehr nakhjavani from the department of internal medicine, division of endocrinology and metabolism, tehran university of medical sciences, mohammad hasan bastanhagh reza kassayan radina eshtiaghi afsar asadi mohammad rajai

we studied the clinical, radioisotopic, and pathologic characteristics and the incidence of cancer in clinically solitary cold nodules of the thyroid in an iodinedeficient area. the study included retrospective analysis of 765 patients who underwent thyroidectomy for a clinically single cold nodule in a ten-year period. we compared the pathological findings with clinical data. in pathological e...

2013
Eleonore Fröhlich Richard Wahl Barbara Czarnocka Leonidas Duntas

Thyroid cancer is the commonest endocrine malignancy but represents only 1% of all cancers. Although the prognosis of differentiated thyroid cancer is good, the survival time of anaplastic and of medullary thyroid cancer is still very short. More precise diagnosis with better stratification of patients and identification of risk patients may improve the prognosis of thyroid cancer. Treatment of...

2014
So-Jung Yeo Kyu-Jin Kim Bo-Yeon Kim Chan-Hee Jung Seung-Won Lee Jeong-Ja Kwak Chul-Hee Kim Sung-Koo Kang Ji-Oh Mok

Metastasis to the primary thyroid carcinoma is extremely rare. We report here a case of colonic adenocarcinoma metastasis to medullary thyroid carcinoma in a 53-yr old man with a history of colon cancer. He showed a nodular lesion, suggesting malignancy in the thyroid gland, in a follow-up examination after colon cancer surgery. Fine needle aspiration biopsy (FNAB) of the thyroid gland showed t...

2011
Maria E. Cabanillas Mimi I. Hu Jean-Bernard Durand Naifa L. Busaidy

Tyrosine kinase inhibitors (TKIs) which target angiogenesis are promising treatments for patients with metastatic medullary and differentiated thyroid cancers. Sorafenib, sunitinib, and pazopanib are commercially available drugs which have been studied in these diseases. Vandetanib is the first drug approved in the United States for treatment of medullary thyroid cancer. These TKIs are used as ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید